Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy
Blood Adv
.
2023 May 23;7(10):2241-2244.
doi: 10.1182/bloodadvances.2022008621.
Authors
Kaitlin Annunzio
1
,
Michael Cackovic
2
,
David Bond
1
,
Yazeed Sawalha
1
,
Timothy J Voorhees
1
,
Walter Hanel
1
,
Lapo Alinari
1
,
Robert Baiocchi
1
,
John Reneau
1
,
Jonathan Brammer
1
,
Kami Maddocks
1
,
Beth Christian
1
,
Narendranath Epperla
1
Affiliations
1
Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH.
2
Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH.
PMID:
36287222
PMCID:
PMC10196908
DOI:
10.1182/bloodadvances.2022008621
No abstract available
MeSH terms
B-Lymphocytes / pathology
Female
Humans
Lymphoma, Large B-Cell, Diffuse* / pathology
Pregnancy
Treatment Outcome